NCT06461286View on ClinicalTrials.gov

SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
OPA1 Gene MutationAutosomal Dominant Optic AtrophyHereditary Optic AtrophiesKjer Optic Atrophy
Interventions
DRUG

PYC-001

Single Group Assignment

Trial Locations (2)

2000

RECRUITING

Save Sight Institute - Sydney Eye Hospital, Sydney

3002

RECRUITING

Center for Eye Research Australia (CERA), East Melbourne

Sponsors

Lead Sponsor

PYC Therapeutics
All Listed Sponsors
lead

PYC Therapeutics

INDUSTRY

NCT06461286 - SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew) | Biotech Hunter | Biotech Hunter